Ads
related to: medication for macular degeneration- Clinical Trial Data
View Clinical Trial Data On Safety
Of A DME Treatment
- Patient Financial Support
Help Your Patients Reduce Their
Financial Burden For Treatment
- HCP Resources
Find HCP & Practice Resources
For Viewing Or Download
- Dosing Information
See The Dosing Options And Schedule
For A Wet AMD Treatment
- Safety Information
Find ISI & Prescribing Info For A
Wet AMD And DME Treatment
- Mechanism Of Action
View The Proposed MOA For An FDA
Approved Therapy For nAMD & DME
- Clinical Trial Data
Search results
Results from the WOW.Com Content Network
The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions. Biosimilars Yesafili and Opuviz...
Anti-VEGF medication injected into the eye, laser coagulation, photodynamic therapy [1] Frequency. 8.7% global prevalence in 2020 [2] Macular degeneration, also known as age-related macular degeneration ( AMD or ARMD ), is a medical condition which may result in blurred or no vision in the center of the visual field. [1]
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF ( / vɛdʒˈɛf /) therapy or medication, is the use of medications that block vascular endothelial growth factor. This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab ...
Aflibercept, sold under the brand names Eylea among others, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals. It is an inhibitor of vascular endothelial growth factor (VEGF).
Conbercept, sold under the commercial name Lumitin, is a novel vascular endothelial growth factor (VEGF) inhibitor used to treat neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). The anti-VEGF was approved for the treatment of neovascular AMD by the China State FDA (CFDA) in December 2013.
Macular degeneration happens with age, when the macula, at the center of the retina — “the part of the eye that sees the world for us,” Dr. Vlad Diaconita, a retinal and vitreoretinal ...
Ads
related to: medication for macular degeneration